NASDAQHealth CareMedical Instruments & SuppliesSnapshot 2026-07-09
Reading MDLN? Create a free portfolio, then add this holding for ongoing Reports and tracking. No credit card.
Create your account →QuarterlyIQ Insights · MDLN
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Chief Operating Officer — Stephen L. Miller: Stephen L. Miller is retiring from his role as Chief Operating Officer due to health-related reasons.
Entry Into a Material Definitive Agreement. Refinancing Transactions Overview On May 28, 2026, Medline Borrower, LP (the “ Issuer ”) and Medline Co-Issuer, Inc. (the “ Co-Issuer ” and, together with the Issuer, the “ Issuers ”), indirect subsidiaries of Medline Inc. (the “ Company ”), issued $1,250.0 million aggregate principal amount of 5.000% senior secured notes due 2031 (the “ 2031 Notes ”) and $750.0 million aggregate principal amount of 5.250% senior secured notes due 2033 (the “ 2033 N…
Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The information required by
Results of Operations and Financial Condition. On May 6, 2026, Medline Inc. issued an earnings press release announcing results for the first quarter ended March 28, 2026. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), nor shall it be deemed incorporated by reference into any filing under t…
Results of Operations and Financial Condition. On February 25, 2026, Medline Inc. (the " Company ") issued an earnings press release announcing results for the fourth quarter and full year ended December 31, 2025. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), nor shall it be deemed incorpo…
Material Modification to Rights of Security Holders. The information set forth under
Entry into a Material Definitive Agreement. In connection with the initial public offering (the “ Offering ” or the “ IPO ”) by Medline Inc. (the “ Company ”) of its Class A common stock, par value $0.0001 per share (the “ Class A Common Stock ”), described in the prospectus (the “ Prospectus ”), dated December 16, 2025, filed with the Securities and Exchange Commission pursuant to Rule 424(b) of the Securities Act of 1933, as amended (the “ Securities Act ”), which is deemed to be part of th…
Director — Todd M. Bluedorn: Appointment of Todd M. Bluedorn to the Board of Directors and his inclusion on the Audit Committee.
Other Events. On December 18, 2025, the Company completed the Offering of 248,439,654 shares of Class A Common Stock (including shares issued pursuant to the exercise in full of the underwriters’ option to purchase additional shares) for cash consideration of $29.00 per share (net of underwriting discounts). As contemplated in the Prospectus, the Company has used the proceeds (net of underwriting discounts) from the issuance of 179,000,000 shares ($5,078 million) in the Offering to purchase a…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
